SARS-CoV-2 targets multiple cells expressing ACE-2, which would lead to corresponding dysfunction and alteration of the cardiometabolic environment such as new onset diabetes and chronic kidney disease (19). This evidence concerns the gene ACE2 and chronic kidney disease.